GSK-205694

Study Sponsor: GSK

Study Title

An open-label, randomized, single-dose, two-period cross-over study to evaluate bioequivalence of GSK3542503 hydrochlorothiazide + amiloride hydrochloride 50 mg: 5 mg fixed dose combination tablets versus reference product in healthy adult participants under fasting conditions

Medicine or Vaccine (generic name)

GSK3542503

Sponsor Identification Number

205694

Trial Registry Identification Number(#'s)

NCT03031496

Medical Condition

Hypertension

Phase

Phase 1

Link to study details on the GSK Clinical Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=205694

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT03031496

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

An annotated case report form is not available for this study. A blank case report form will be provided.

Date Added to this Site

March 2021